cbdMD (YCBD)
(Delayed Data from AMEX)
$0.72 USD
+0.01 (0.75%)
Updated May 17, 2024 03:59 PM ET
After-Market: $0.70 -0.02 (-2.17%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
YCBD 0.72 +0.01(0.75%)
Will YCBD be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for YCBD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for YCBD
Analyst Maintains ‘Buy’ Rating for cbdMD Amidst Challenges, Citing Brand Strength and Strategic Initiatives
YCBD Stock Earnings: cbdMD Misses EPS, Misses Revenue for Q2 2024
cbdMD Inc (YCBD) Q2 2024 Earnings Call Transcript Highlights: Navigating Challenges with ...
cbdMD's Financial Results: Cost-Cutting Measures For Positive Cash Flow Amid Increasing Losses
cbdMD GAAP EPS of -$1.35, revenue of $4.4M